GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology

Proprietary analytical method for precise Factor XI (FXI) measurement published in the Journal of Microbiology and Biotechnology Novel IgG Blocker eliminates heterophilic antibody interference, ensuring clinical-grade purity and mitigating thromboembolic risks YONGIN, South Korea, April...